Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Details)

v3.10.0.1
Summary of Significant Accounting Policies (Details) - USD ($)
6 Months Ended
Jun. 30, 2018
Dec. 31, 2017
Summary of Significant Accounting Policies (Textual)    
Common stock subject to possible redemption, shares 10,713,847 10,675,764
Description of net income (loss) per common share The Company has not considered the effect of (1) warrants sold in the Initial Public Offering and Private Placement to purchase 6,001,250 shares of common stock and (2) rights sold in the Initial Public Offering and Private Placement that convert into 1,200,250 shares of common stock, in the calculation of diluted income (loss) per share, since the exercise of the warrants and the conversion of the rights into shares of common stock is contingent upon the occurrence of future events and the inclusion of such warrants and rights would be anti-dilutive.  
Federal depository insurance coverage amount $ 250,000  
Assets held in Trust Account 31,249 $ 16,699
U.S. Treasury Bills $ 117,326,772 $ 116,571,318
U.S. corporate income tax rate, percentage 21.00%